Prof. Dr. med. Hana Algül, MD, PhD

Prof. Dr. med. Hana Algül, MD, PhD is a renowned Clinician Scientist specializing in tumor metabolism. With a rich academic background in medicine from the University of Ulm and the University of California Davis, USA, Prof. Dr. Algül has been working diligently at the Klinikum rechts der Isar of TUM since 2003. As the Chair of Tumor Metabolism at TUM since 2017, Prof. Dr. Algül has contributed significantly to the field with hundreds of scientific publications, focusing on various aspects of pancreatic cancer and inflammation. Prof. Dr. Algül's research sheds light on the mechanisms that drive pancreatic diseases, offering insights into potential treatments and preventive measures. His expertise in exploring the connection between chronic inflammation and cancer in the pancreas has garnered international recognition. Through innovative studies on tumor progression and metastasis, Prof. Dr. Algül continues to make significant contributions to the field, ultimately improving patient outcomes and advancing the understanding of pancreatic disorders. Professor Algül is an expert in pancreatic cancer, with a primary focus on tumor metabolism and immune system interactions. His research explores how cancer cachexia—a severe metabolic disorder—relates to pancreatic carcinoma, particularly through the process of autophagy. Using in vivo models, he aims to identify new therapeutic targets for cachexia. Additionally, he investigates spontaneous and inflammation-driven pancreatic carcinogenesis, seeking to understand immune system effects on tumorigenesis. He has participated in over 40 clinical trials across phases I, II, and III.